Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CBIO

CRESCENT BIOPHARMA, INC.

CIK 0001253689 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$17.15
↑ 0.92 (5.67%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$637.02M
P/E Ratio
-3.58
EPS
Not covered
Dividend Yield
Not covered
52W Position
45%
Beta
0.85

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
3.90
P/S
Not covered
EV/Revenue
Not covered
ROE
-109.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 45%
$8.72$27.41

Latest Financials

2025-12-31 FY
Revenue
$10.84M
Net Income
-$153.94M
Total Assets
$240.29M
Free Cash Flow
-$72.45M

Recent news